This clinical quality registry aims to improve myeloma outcomes by providing an evidence base for the best strategies to diagnose, treat and support people with myeloma and related diseases.
Patients accrued
Patients with multiple myeloma
Number of approved sites
Biobank participants
$5.3 million funding over 5 years approved for APAC MRDR
Read moreWe invite you to the free MRDR webinar: 5 Sept, 4-5pm
Read moreReal-time feedback of patient-reported outcomes feasible for patients and clinicians!
Read more